Skip to main content

Table 1 Demographic and clinical characteristics of patients with multiple sclerosis according to cerebrospinal fluid proinflammatory cytokine content a

From: Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis

Characteristics   IL-1β
  Total + P-value
Number 170 77 93  
Gender (M/F) 62/108 27/50 35/58 0.75
Age (years) 36.3 ± 9.5 37.8 ± 10.1 35.1 ± 8.8 0.07
Disease duration (years) 10.5 ± 5.3 10.9 ± 5.9 10.2 ± 4.8 0.39
EDSS 2.2 ± 1.7 2.8 ± 1.9 1.7 ± 1.4 < 0.01
BREMS 0.34 ± 0.9 0.47 ± 1.0 0.23 ± 0.8 0.10
  1. a+, detectable; −, undetectable; BREMS, Bayesian Risk Estimate for Multiple Sclerosis; EDSS, Expanded Disability Status Scale; F, female; IL-1β, interleukin 1β; M, male. Data are mean ± SD.